HYPERFINE INC (HYPR)
US44916K1060 - Common Stock
We assign a fundamental rating of 3 out of 10 to HYPR. HYPR was compared to 188 industry peers in the Health Care Equipment & Supplies industry. While HYPR has a great health rating, there are worries on its profitability. HYPR is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
HYPR had negative earnings in the past year.
In the past year HYPR has reported a negative cash flow from operations.
1.2 Ratios
With a Return On Assets value of -59.11%, HYPR is not doing good in the industry: 73.26% of the companies in the same industry are doing better.
HYPR's Return On Equity of -70.32% is on the low side compared to the rest of the industry. HYPR is outperformed by 60.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -59.11% | ||
| ROE | -70.32% | ||
| ROIC | N/A |
ROA(3y)-44.52%
ROA(5y)N/A
ROE(3y)-48.79%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
HYPR has a worse Gross Margin (46.01%) than 60.96% of its industry peers.
HYPR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 46.01% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
HYPR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HYPR has been increased compared to 1 year ago.
HYPR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
HYPR has an Altman-Z score of -2.84. This is a bad value and indicates that HYPR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -2.84, HYPR is doing worse than 65.24% of the companies in the same industry.
HYPR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -2.84 |
ROIC/WACCN/A
WACC9.07%
2.3 Liquidity
HYPR has a Current Ratio of 6.44. This indicates that HYPR is financially healthy and has no problem in meeting its short term obligations.
HYPR has a better Current ratio (6.44) than 81.82% of its industry peers.
A Quick Ratio of 5.73 indicates that HYPR has no problem at all paying its short term obligations.
HYPR has a Quick ratio of 5.73. This is amongst the best in the industry. HYPR outperforms 82.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.44 | ||
| Quick Ratio | 5.73 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 13.64% over the past year.
Looking at the last year, HYPR shows a very strong growth in Revenue. The Revenue has grown by 61.90%.
HYPR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 234.79% yearly.
EPS 1Y (TTM)13.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.67%
Revenue 1Y (TTM)61.9%
Revenue growth 3Y234.79%
Revenue growth 5YN/A
Sales Q2Q%56.22%
3.2 Future
The Earnings Per Share is expected to grow by 10.81% on average over the next years. This is quite good.
The Revenue is expected to grow by 18.70% on average over the next years. This is quite good.
EPS Next Y6.77%
EPS Next 2Y4.65%
EPS Next 3Y4.35%
EPS Next 5Y10.81%
Revenue Next Year18.17%
Revenue Next 2Y25.82%
Revenue Next 3Y25.52%
Revenue Next 5Y18.7%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for HYPR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HYPR. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.65%
EPS Next 3Y4.35%
5. Dividend
5.1 Amount
HYPR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
HYPERFINE INC
NASDAQ:HYPR (11/22/2024, 8:00:02 PM)
1.02
+0.04 (+4.55%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap74.41M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -59.11% | ||
| ROE | -70.32% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 46.01% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.19
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 6.44 | ||
| Quick Ratio | 5.73 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)13.64%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y6.77%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)61.9%
Revenue growth 3Y234.79%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y